文献速递免疫规划

携带S-HBsAg的植物冻干制剂作为乙肝口服加强疫苗

Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV.
PubMed 文献 · Vaccine · 2018-09-07

研究在小鼠免疫试验中评估携带S-HBsAg的植物冻干制剂作为口服加强疫苗的效果,发现肌注初免后双次口服加强(间隔6周)与标准肌注接种效果相当,2×5或200 ng剂量可引发有效且完全全身性应答,黏膜佐剂或铝佐剂无益或有害。

要点

  • 肌注初免后双次口服加强(间隔6周)与标准肌注接种效果相当。
  • 2×5或200 ng口服剂量触发有效且完全全身性应答。
  • 低剂量植物冻干制剂作为口服加强疫苗可能无需外源佐剂。

核心结论

  • 低剂量浓缩S-HBsAg植物冻干制剂被证明是有效且便捷的口服加强疫苗。

研究设计与样本

  • 系列小鼠免疫试验,口服给予先前优化的积累S-HBsAg的植物冻干制剂。

主要发现

  • 肌注初免后双次口服加强(间隔6周)与标准肌注接种效果相当。
  • 测试剂量中2×5或200 ng触发有效且完全全身性应答。
  • 黏膜佐剂CTB或皂树皮皂苷以及铝佐剂对免疫应答无影响或呈负面影响。
  • 与植物提取物中释放的抗原相比,冻干细胞内S-HBsAg包封对免疫应答刺激有正面效果。

临床怎么用

  • 混合注射-口服途径免疫结果为植物源性乙肝口服疫苗进一步标准化及免疫应答细节与健康状况影响研究提供基础。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A formulation of a defined antigen dosage together with an appropriate and convenient immunisation regime are the main problems of a plant-derived oral vaccine against HBV. Both factors have to be mutually adjusted to ensure efficacious vaccination and to minimise the risk of oral tolerance acquisition. As based on previous research, solely oral immunisation appears to be of limited effectiveness, but a combined immunisation scheme via injection priming and oral boosting can be proposed. Thus, the previously optimised plant lyophilisate with accumulated S-HBsAg was orally administered in a series of mouse immunisation trials. The impact of various S-HBsAg oral dosages and concentrations on the induction of an active immune response was studied. Immunisation via i.m. priming followed by double oral boosting in 6-week intervals was comparably efficient as standard i.m. vaccination. Among the tested dosages, 2× 5 or 200 ng triggered effective and exclusively systemic responses. Mucosal adjuvants CTB or quillaja bark saponins as well as alhydrogel either had no or a negative effect on immune response, which indicates that a low-dosed plant lyophilisate as an oral booster vaccine may not require exogenous adjuvants. Additionally, a positive effect of S-HBsAg encapsulation in lyophilised cells on immune response stimulation was confirmed by comparison with the antigen released in the plant extract. The low-dosed plant lyophilisate with concentrated S-HBsAg was proven as an effective and convenient oral booster vaccine. Results of immunisation via a mixed injection-oral route provide the foundation for research on further standardisation of a plant-derived oral vaccine against HBV and details of immune response together with effects for health condition.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Pniewski T, Milczarek M, Wojas-Turek J, et al. Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV. Vaccine. 2018. PMID: 30197284. doi:10.1016/j.vaccine.2018.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。